NEXGEL Appoints Chief Accounting Officer of Shutterstock, Steve Ciardiello, CPA, to its Board of Directors
MWN-AI** Summary
NEXGEL, Inc. (NASDAQ: NXGL), a prominent provider of ultra-gentle hydrogels for healthcare and consumer applications, has recently appointed Steve Ciardiello, CPA, as a member of its Board of Directors. Mr. Ciardiello, who currently serves as the Chief Accounting Officer at Shutterstock, Inc. (NYSE: SSTK), brings over 25 years of extensive experience in finance, corporate governance, and strategic execution in high-growth, publicly traded environments.
Adam Levy, CEO of NEXGEL, expressed enthusiasm about Mr. Ciardiello’s appointment, highlighting his financial acumen and deep understanding of public company operations. Levy anticipates that Ciardiello's expertise will significantly benefit NEXGEL as the company navigates its next growth phase.
In his role at Shutterstock since 2016, Ciardiello has led numerous financial transformation initiatives, enhancing reporting efficiency and streamlining enterprise resource planning processes. His background includes several leadership positions where he oversaw the redesign of financial operations and implemented global ERP systems. Ciardiello is also equipped with over 15 years of experience in Big 4 public accounting.
In his inaugural statement as a board member, Ciardiello expressed his honor in joining NEXGEL during a pivotal time of innovation and growth, and he looks forward to leveraging his financial and operational expertise to advance the company's mission.
NEXGEL is renowned for its innovative healthcare, beauty, and over-the-counter products, with a strong focus on developing electron-beam cross-linked hydrogels. The company markets a range of products that include popular brands such as Silverseal®, Hexagels®, and Turfguard® and has built strategic manufacturing partnerships with leading consumer healthcare firms.
As NEXGEL embarks on its next chapter, the addition of Steve Ciardiello to the board underscores its commitment to enhancing corporate governance and operational excellence.
MWN-AI** Analysis
The recent appointment of Steve Ciardiello, CPA, to the Board of Directors at NEXGEL, Inc. is a significant development that could influence the company's trajectory as it seeks to broaden its market reach and innovate within its product offerings. With over 25 years in finance, especially as the Chief Accounting Officer of Shutterstock, Ciardiello brings invaluable experience in corporate governance, financial strategy, and operational efficiency.
Investors should view Ciardiello's appointment as a strategic move to bolster NEXGEL's financial oversight and reporting capabilities, which are critical for a company in the growth phase. His track record of leading financial transformation initiatives reflects a strong alignment with NEXGEL’s goals of scaling operations and enhancing its market presence, especially in a rapidly evolving healthcare and consumer product landscape.
Moreover, NEXGEL's existing product portfolio of high-water-content hydrogels presents substantial growth opportunities, particularly as demand for innovative healthcare solutions continues to rise. As a company that has developed its unique proprietary technology over two decades, the combination of Ciardiello's financial acumen with NEXGEL's R&D capabilities could lead to enhanced product offerings and strategic partnerships.
For current and prospective investors, NEXGEL (NASDAQ: NXGL) may present an attractive opportunity. However, it's essential to monitor the execution of the company's strategic initiatives and evaluate how effectively it can harness Ciardiello's financial expertise. Given the inherent risks in growth-stage companies as highlighted in their forward-looking statements, potential investors should perform due diligence and consider market conditions, competitive pressures, and NEXGEL's capacity to innovate and adapt.
Overall, the appointment signals a commitment to maintaining rigorous financial practices while pursuing aggressive growth, making NXGL worth watching in the coming quarters as it progresses in this new leadership phase.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
LANGHORNE, Pa., Aug. 05, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced the appointment of Steve Ciardiello, CPA, to its Board of Directors. With more than 25 years of experience as a senior finance executive and current Chief Accounting Officer of Shutterstock, Inc. (NYSE: SSTK), Mr. Ciardiello has a proven track record of financial leadership, strategic execution, and corporate governance in high-growth, publicly traded companies.
“Steve’s extensive experience, financial leadership and his deep understanding of public company operations make him an exciting addition to our Board,” said Adam Levy, CEO of NEXGEL. “His financial acumen and leadership experience will be of great value to NEXGEL as we enter this next stage of growth.”
Mr. Ciardiello commented, “I am honored to join the Board of Directors at NEXGEL during such an exciting phase of innovation and growth. I look forward to contributing my financial and operational expertise to support NEXGEL’s mission and help scale its impact worldwide.”
As the CAO of Shutterstock, a leading global creative platform offering high-quality digital content, Mr. Ciardiello leads a global finance team responsible for SEC reporting, tax, internal audit, and general accounting. Since joining Shutterstock in 2016, he has led numerous financial transformation initiatives, improved reporting efficiency, and led efforts to streamline enterprise resource planning and financial operations. Prior to Shutterstock, Mr. Ciardiello held several finance leadership positions overseeing the redesign of the financial close process and implemented a global ERP system and has over 15 years of Big 4 public accounting experience.
About NEXGEL, Inc.
NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include Silverseal ® , Hexagels ® , Turfguard ® , Kenkoderm ® and Silly George ® . Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.
Forward-Looking Statement
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs, such as “will,” “should,” “would,” “may,” and “could,” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance, or achievements to be materially different from any anticipated results, performance, or achievements for many reasons. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company's forward-looking statements, please see the Company's Annual Report on Form 10-K for the year ended December 31, 2024, including but not limited to the discussion under “Risk Factors” therein, which the Company filed with the SEC and which may be viewed at http://www.sec.gov/ .
Investor Contacts:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
NEXGEL@KCSA.Com
FAQ**
How will the appointment of Steve Ciardiello to the Board of Directors enhance NexGel Inc's financial strategy as they progress with their growth plans, particularly concerning the NexGel Inc Warrant NXGLW?
What specific financial transformation initiatives does Steve Ciardiello plan to implement at NexGel Inc to optimize operations and reporting efficiency, especially in relation to the NexGel Inc Warrant NXGLW?
Considering NexGel Inc's focus on growth and innovation, how might the company leverage its strategic relationships with consumer healthcare firms to strengthen its market position, particularly for the NexGel Inc Warrant NXGLW?
What risks or challenges does NexGel Inc foresee in achieving its growth objectives under the new board leadership, and how are these factors influencing investor sentiment regarding the NexGel Inc Warrant NXGLW?
**MWN-AI FAQ is based on asking OpenAI questions about NexGel Inc (NASDAQ: NXGL).
NASDAQ: NXGL
NXGL Trading
14.42% G/L:
$0.595 Last:
377,697 Volume:
$0.53 Open:
